Adenosine
| A | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 267.24 g/mol [1] |
| Appearance | Needles (from water +3/2) [1] |
| Odor | Odorless [1] |
| Taste | Mild, saline, or bitter taste [1] |
| Melting point | 235.5 °C [1] |
| Decomposition | When heated to decomposition, it emits toxic funes of /nitrogen oxides/. [1] |
| Solubility | Water solubility increases by warming and lowering the pH [1] |
| Predicted LogP | -1.1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C10H13N5O4 |
| IUPAC name | (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol |
| SMILES | C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N |
| InChI | InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1 |
| InChIKey | OIRDTQYFTABQOQ-KQYNXXCUSA-N |
| CAS number | 58-61-7 |
| UNII | K72T3FS567 |
| PubChem CID | 60961 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | cleared plasma <30 seconds; half-life <10 seconds |
| Metabolism | Rapidly converted to inosine and adenosine monophosphate |
| Excretion | can leave cell intact or can be degraded to hypoxanthine, xanthine, and ultimately uric acid |
| Routes of administration | Intravenous |
| Toxicity [] | |
|---|---|
| LD50 | Mouse: - ip: 500 mg/kg [1] |
Adenosine (also known as Adenocard, Adenoscan, Adenine riboside, Nucleocardyl, β-D-Adenosine, Boniton, Myocol, Sandesin, Adenosin or β-Adenosine).
Chemistry
Stereochemistry []
Adenosine is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
Adenosine matches Lipinski's rule of five.Pharmacology
ATC Classification
- cardiovascular system (C)
- cardiac therapy (C01)
- other cardiac preparations (C01E)
- other cardiac preparations (C01EB)
- (C01EB10)
- adenosine (C01EB10)
MeSH Classification
- analgesics (M0001067)
- anti-arrhythmia agents (M0001326)
- vasodilator agents (M0022559)
- purinergic p1 receptor agonists (M0545332)
Mechanism of action []
Agonism of adenosine receptors A1 and A2 reduces conduction time in the atrioventricular node of the heart. Conduction time is decreased by inducing potassium efflux and inhibiting calcium influx through channels in nerve cells, leading to hyperpolarization and and increased threshold for calcium dependent action potentials. Decreased conduction time leads to an antiarrhythmic effect. Inhibition of calcium influx, reduces the activity of adenylate cyclase, relaxing vascular smooth muscle. Relaxed vascular smooth muscle leads to increased blood flow through normal coronary arteries but not stenotic arteries, allowing thallium-201 to be more readily uptaken in normal coronary arteries. [1]
Interactions []
Medical side effects []
101 side effects listed on drug labels in SIDER 4.1 (adenosine).
- Chest pain
- Chest discomfort
- Chest pressure
- Flushing
- Abdominal discomfort
- Dizziness
- Lightheadedness
- Syncope
- Dyspnoea
- Discomfort
- General discomfort
- Limb discomfort
- Nausea
- Atrioventricular block first degree
- Atrioventricular block second degree
- Electrocardiogram ST segment depression
- Headache
- Head pressure
- Nervousness
- Tension
- Paraesthesia
- Tingling sensation
- Hypotension
- Arrhythmia
- Hypoaesthesia
- Sensory loss
- Anaphylactic shock
- Angioedema
- Apnoea
- Atrial fibrillation
- Bronchospasm
- Bronchoconstriction
- Dermatitis
- Rash
- Cardiac arrest
- Cardiac disorder
- Cardiac failure
- Hypertension
- Hyperventilation
- Mediastinal disorder
- Myocardial infarction
- Acute coronary syndrome
- Palpitations
- Convulsion
- Sinoatrial block
- Device capturing issue
- Cerebrovascular accident
- Hyperhidrosis
- Shock
- Loss of consciousness
- Tachycardia
- Sinus tachycardia
- Torsade de pointes
- Urticaria
- Ventricular fibrillation
- Ventricular tachycardia
- Non-sustained ventricular tachycardia
- Vomiting
- Ventricular arrhythmia
- Atrioventricular block complete
- Haemorrhage intracranial
- Injection site reaction
- Myocardial ischaemia
- Respiratory arrest
- Throat tightness
- Bradycardia
- Blood pressure increased
- Electrocardiogram ST segment elevation
- Sinus arrest
- Respiratory failure
- Coronary artery disease
- Asthenia
- Atrioventricular block
- Nodal block
- Back pain
- Back distress
- Cough
- Somnolence
- Hypersensitivity
- Nasal congestion
- Pain
- Supraventricular extrasystoles
- Scotoma
- Tinnitus
- Tremor
- Dry mouth
- Pollakiuria
- Micturition urgency
- Burning sensation
- Mood swings
- Affect lability
- Ventricular extrasystoles
- Intracranial pressure increased
- Extrasystoles
- Anxiety
- Agitation
- Musculoskeletal discomfort
- Dysgeusia
- Vision blurred
- Grand mal convulsion
- Ear discomfort
Indications
- Atrial fibrillation
- Atrial flutter
- Cardiac disorder
- Convulsion
- Coronary artery disease
- Myocardial ischaemia
- Nodal block
- Paroxysmal supraventricular tachycardia
- QRS complex
- Sinus rhythm
- Supraventricular tachycardia
- Vascular resistance systemic
- Ventricular tachycardia
- Wolff-Parkinson-White syndrome
Legal status []
- Other: Adenosine is a Rx-only.
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 60961, Adenosine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/60961
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Adenosine. UNII: K72T3FS567. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/K72T3FS567
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 07:05:35 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 07:05:31 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 07:05:31 |
| gsrs | ok | 2026-11-20 07:05:32 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0000050) | 2026-11-20 07:05:31 |
| kegg | ok | 2026-11-20 07:05:33 |
| pubchem | ok | 2026-11-20 07:05:31 |
| missing (no r/tripreports posts mention it) | 2026-11-20 07:05:31 | |
| sider | ok | 2026-11-20 07:05:32 |
| structure | ok | 2026-11-20 07:05:31 |
| wikipedia | ok | 2026-11-20 07:05:32 |